MENU
NERV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Minerva Neurosciences (NERV) Ownership - Who owns Minerva Neurosciences?
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1500 District Avenue
Phone
+1 617 600-7373
Employees
9
Web
https://www.minervaneurosciences.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.26M
P/E Ratio
8.47
Total Cash
21.36M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash/Share
3.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NERV
Capitalization
11.3M
P/E Ratio
8.47
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash
21.4M
Total Cash/Share
3.05
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-25.69M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
699
Current Ratio
7.85
Current Revenue Per Employee
3167353.80
Dividends Per Share - Security
N/A
EBITDA
6.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
3.06
Shares Held By Institutions
12.1M
Shares Outstanding - Current
6.99M
Total Liabilities
62.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-27.530
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1500 District Avenue
Phone
+1 617 600-7373
Employees
9
Web
https://www.minervaneurosciences.com